PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jcinvestThe Journal of Clinical InvestigationCurrent IssueArchiveSubscriptionAbout the Journal
 
J Clin Invest. 2010 May 3; 120(5): 1441–1453.
Published online 2010 April 1. doi:  10.1172/JCI40927
PMCID: PMC2860928

This article has been retractedRetraction in: J Clin Invest. 2012 December 3; 122(12): 4748    See also: PMC Retraction Policy

Connexin 43 acts as a cytoprotective mediator of signal transduction by stimulating mitochondrial KATP channels in mouse cardiomyocytes

Abstract

Potassium (K+) channels in the inner mitochondrial membrane influence cell function and survival. Increasing evidence indicates that multiple signaling pathways and pharmacological actions converge on mitochondrial ATP-sensitive K+ (mitoKATP) channels and PKC to confer cytoprotection against necrotic and apoptotic cell injury. However, the molecular structure of mitoKATP channels remains unresolved, and the mitochondrial phosphoprotein(s) that mediate cytoprotection by PKC remain to be determined. As mice deficient in the main sarcolemmal gap junction protein connexin 43 (Cx43) lack this cytoprotection, we set out to investigate a possible link among mitochondrial Cx43, mitoKATP channel function, and PKC activation. By patch-clamping the inner membrane of subsarcolemmal murine cardiac mitochondria, we found that genetic Cx43 deficiency, pharmacological connexin inhibition by carbenoxolone, and Cx43 blockade by the mimetic peptide 43GAP27 each substantially reduced diazoxide-mediated stimulation of mitoKATP channels. Suppression of mitochondrial Cx43 inhibited mitoKATP channel activation by PKC. MitoKATP channels of interfibrillar mitochondria, which do not contain any detectable Cx43, were insensitive to both PKC activation and diazoxide, further demonstrating the role of Cx43 in mitoKATP channel stimulation and the compartmentation of mitochondria in cell signaling. Our results define a role for mitochondrial Cx43 in protecting cardiac cells from death and provide a link between cytoprotective stimuli and mitoKATP channel opening, making Cx43 an attractive therapeutic target for protection against cell injury.

Introduction

Ischemic injury can result in cell death and irreversible loss of function in a variety of biological systems (1, 2). Understanding of the intracellular signaling mechanisms by which cells protect themselves against ischemia-induced damage bears great clinical significance with respect to the treatment and prevention of tissue injury (3). A powerful cytoprotective adaptation can be produced by brief episodes of ischemia followed by reperfusion before sustained ischemia or by pharmacological agents such as diazoxide mimicking these preconditioning effects (1, 2). Ischemic preconditioning (IP) leads to release of hormones or agonists that bind to G protein–coupled receptors and activate signaling pathways (1, 4). Mitochondria are essential targets and effectors in these cytoprotective cascades (1, 5). Particularly, it has been suggested that opening of the mitochondrial adenosine triphosphate–sensitive K+ (mitoKATP) channel and activation of cytosolic and mitochondrial protein kinase C (PKCε) play a critical role in protection against ischemic cell injury (1, 6, 7). However, the molecular structure of mitoKATP channels remains unresolved, and no mitochondrial phosphoprotein has yet been identified that may mediate cytoprotection by these kinases (6, 8).

Cytoprotection by both pharmacological and IP is abolished in transgenic animals with connexin 43 deficiency (911). Connexin 43 (Cx43), the main gap junction protein, is predominantly localized in the sarcolemma but is also found in the inner mitochondrial membrane (Figure (Figure1)1) (10, 12). To determine how mitochondrial Cx43 might be involved in the preconditioning pathway, we used direct single-channel patch-clamp recordings of cardiac mitoplasts to identify a possible link among mitoKATP channel function, mitochondrial Cx43, and PKC activation.

Figure 1
Cx43 is present in isolated subsarcolemmal mitoplasts.

Results

By patch-clamping the inner membrane of subsarcolemmal mitochondria (mitoplasts) prepared from isolated cardiomyocytes, we verified the existence of mitochondrial KATP channels in wild-type mice. In K+ solution (150 mM KCl), voltage-dependent single-channel currents with a unitary conductance of 13.7 ± 0.3 pS, an amplitude of –0.83 ± 0.05 pA, and an open probability of 0.29% ± 0.08% (Po,total; at –60 mV, n = 22) were obtained (Figure (Figure2,2, A and B, Figure Figure3,3, B and C, and Table Table1).1). These currents could be activated by the mitoKATP channel opener diazoxide (100 μM), which significantly increased the open probability (Po,total, 4.30% ± 0.40%, n = 16, P < 0.05) and mean open time without affecting single-channel amplitude and conductance (Figure (Figure2A,2A, Figure Figure3,3, B, C, and E, and Table Table1).1). MitoKATP channels did not exhibit time-dependent activation or run-down (continuous 9-second pulse: Po,total, 0.28% ± 0.09% and 4.21% ± 0.50% at baseline and under diazoxide, respectively; n = 6). Diazoxide-stimulated mitoKATP channel activity was inhibited by the nonselective mitoKATP inhibitor glibenclamide (10 μM; Po,total, 0.35% ± 0.06%, n = 8) (Figure (Figure2A2A and Table Table1),1), the selective mitoKATP inhibitor 5-hydroxydecanoic acid (100 μM; Po,total 0.26% ± 0.16%, n = 6), and magnesium adenosine triphosphate (MgATP; 100 μM; Po,total 0.55% ± 0.09%, n = 5). Thus, mitoKATP channels are present in wild-type mice and exhibit properties similar to those previously reported for rats (13, 14).

Figure 2
MitoKATP single-channel activation by diazoxide (100 μM) is independent of ROS.
Figure 3
MitoKATP single-channel activation by diazoxide (100 μM) is dependent on the presence of mitochondrial Cx43.
Table 1
Gating parameters of mitoKATP channels and effects of diazoxide, L-NAC, glibenclamide, and MgATP on mitoKATP single-channel behavior in wild-type mice in the absence or presence of carbenoxolone

To evaluate whether the diazoxide effect on mitoKATP channel activity might be mediated via ROS, we (a) measured the effect of diazoxide on mitochondrial H2O2 production by the Amplex UltraRed assay (15); and (b) performed mitoKATP channel recordings in the presence of the ROS scavenger N-acetyl-l-cysteine (L-NAC) (16, 17). While antimycin A (4 μg/ml), which stimulates ROS formation by inhibiting respiratory complex III, increased the slope of the Amplex UltraRed fluorescence in both mitochondria and mitoplasts; neither the solvent DMSO nor diazoxide (200 μM) altered Amplex UltraRed fluorescence in mitoplasts maintained in our patch-clamp solution (Figure (Figure2,2, E and F), supporting the hypothesis that under our experimental conditions, diazoxide had no relevant unspecific effect on mitochondrial ROS production (18). Moreover, the ROS scavenger L-NAC (5 mM) did no alter baseline mitoKATP channel properties and, notably, did not attenuate diazoxide-induced mitoKATP channel activation (Figure (Figure2,2, C and D, and Table Table1),1), indicating that the stimulation of mitoKATP channels by diazoxide is not mediated through ROS.

Since Cx43 is found in the inner mitochondrial membrane (Figure (Figure1)1) (10, 12) and ischemic or pharmacological preconditioning is undermined by Cx43 deficiency independent of cell-cell coupling by gap junctions (11), we aimed to determine whether mitochondrial Cx43 might be an essential molecular component of the conducting pore of mitoKATP channels or might transfer cytoprotective signaling to these channels. To define the role of mitochondrial Cx43, we used 4 complementary approaches, i.e., single-channel recordings of: wild-type mitoplasts in the presence of (a) the connexin inhibitor carbenoxolone (10 μM) (19) and (b) the Cx43 mimetic peptide 43GAP27 (250 μM) (20); and mitoplasts from (c) heterozygous Cx43-deficient (Cx43+/–) mice (10) and (d) conditional Cx43-deficient mice (4-hydroxytamoxifen–treated [4-OHT–treated] Cx43Cre-ER(T)/fl mice) (21), which have a more pronounced mitochondrial Cx43 knockdown compared with heterozygous Cx43+/– mice (Cx43 content in Cx43+/– mitochondria, 28.9% ± 9.4% of wild-type; in Cx43Cre-ER(T)/fl + 4-OHT, 2.8% ± 1.1% of Cx43fl/fl control; Figure Figure3F),3F), while circumventing direct or indirect compensation of Cx43 deficiency during development. In all these 4 conditions, mitoKATP currents were observed with unitary conductance and baseline single-channel characteristics similar to unstimulated recordings of wild-type mitoplasts without Cx43 inhibition (Figure (Figure3,3, A–D, and Tables Tables1,1, ,2,2, and and3).3). However, carbenoxolone, 43GAP27, and Cx43 deficiency in Cx43+/– and Cx43Cre-ER(T)/fl + 4-OHT mice significantly attenuated mitoKATP stimulation by diazoxide (Figure (Figure3,3, A–E, and Tables Tables113), indicating that the effect of diazoxide on mitoKATP channels is mediated via Cx43. This notion was further supported by an additive effect of 43GAP27 with the genetic Cx43 knockdown, i.e., the Cx43 mimetic peptide abolished diazoxide-mediated KATP channel activation in Cx43+/– mice (Figure (Figure3C3C and Table Table2).2). Inhibition of mitoKATP channels by MgATP (Cx43+/– Po,total, 0.27% ± 0.09%, n = 4) and glibenclamide was retained in the presence of carbenoxolone or 43GAP27 in Cx43+/– mice and in Cx43Cre-ER(T)/fl + 4-OHT mice (Figure (Figure3D3D and Tables Tables113).

Table 2
Gating parameters of mitoKATP channels and effect of the Cx43 mimetic peptide 43GAP27 (250 μM) on mitoKATP single-channel behavior in wild-type and Cx43+/– mice
Table 3
Effect of diazoxide (100 μM) on mitoKATP single-channel behavior in Cx43fl/fl control and Cx43Cre-ER(T)/fl + 4-OHT mice

To test whether diazoxide sensitivity of mitoKATP channels might be rescued by an increased mitochondrial Cx43 content in heterozygous Cx43+/– mice, we compared Cx43 protein levels and diazoxide-induced mitoKATP channel activation in mitochondria from the anterior myocardial wall (AW) subjected to IP (by 10 minutes ischemia and 10 minutes reperfusion) with mitochondria from the posterior myocardial wall (PW; no IP) of the same animals. Consistent with previous reports, IP increased mitochondrial Cx43 levels in the AW versus PW (Figure (Figure4A)4A) (10), which was accompanied by significantly more pronounced diazoxide-mediated mitoKATP channel stimulation (Figure (Figure4,4, B–E), further supporting the hypothesis that Cx43 affects drug-induced mitoKATP channel activity.

Figure 4
IP increases mitochondrial Cx43 content in Cx43+/– mice and rescues diazoxide sensitivity of mitoKATP channels (AE).

Activation of PKCε was implicated in cytoprotection conferred by stimulating G protein–linked receptors, because direct activation of the kinase could mimic preconditioning and inhibitors eliminated protection induced by receptor stimulation (22). Given that sarcolemmal Cx43 is a target of PKCε (23) and PKCε is constitutively localized in mitochondria (24), we reasoned that mitoKATP channels might be activated by mitochondrial PKCε and that this effect might be mediated by mitochondrial Cx43. Thus, we analyzed the effect of PKC activation by PMA (2 μM) and the selective PKCε peptide agonist ψε receptor for activated C kinase (ψεRACK) (0.5 μM) on mitoKATP single-channels in wild-type and Cx43+/– mice. The PKC activator PMA but not its inactive analog 4α-PMA (2 μM) significantly increased mitoKATP channel activity (Figure (Figure5,5, A and B, and Table Table4).4). Similarly, selective stimulation of PKCε by ψεRACK enhanced mitoKATP channel open probability, mean open time, and availability (Figure (Figure5,5, D and E, and Table Table4),4), while both PMA and ψεRACK resulted in significantly diminished activation of mitoKATP channels in Cx43+/– compared with wild-type mice (Figure (Figure5,5, A, B, D, and E, and Table Table4).4). Moreover, Western blot analysis revealed enhanced phosphorylation of Cx43 at the PKC phosphorylation site Ser368 in mitochondria stimulated with ψεRACK (5 μM) versus control (Figure (Figure4,4, F–H), consistent with the notion that Cx43 phosphorylation by PKCε serves to facilitate cytoprotective signal transduction to mitoKATP channels. To further support the interaction of mitochondrial Cx43 and PKCε, we sought to determine whether these two proteins might associate in mitochondrial protein complexes. Immunoprecipitation of Cx43 from isolated mitochondria revealed a signal for PKCε, while immunoprecipitation of PKCε also showed a signal for Cx43 (Figure (Figure5C),5C), indicating a close association of the two proteins. The use of anti-rabbit IgGs for immunoprecipitation did not indicate a coprecipitation of one of the analyzed proteins, excluding unspecific effects.

Figure 5
PKC-mediated stimulation of mitoKATP channel activity is diminished in Cx43+/– mice.
Table 4
Effect of PKC stimulation with PMA (2 μM) and the epsilon-selective peptide ψεRACK (0.5 μM) on mitoKATP single-channel behavior in wild-type compared with Cx43+/– mice

In cardiomyocytes, two mitochondrial populations exist, i.e., subsarcolemmal mitochondria located beneath the plasma membrane and interfibrillar mitochondria found between myofibrils (25). Recently, interfibrillar mitochondria were shown not to contain any detectable Cx43 (12). Given our observations that Cx43 transfers cytoprotective signaling to mitoKATP channels, we therefore reasoned that drug- and PKC-mediated mitoKATP channel stimulation might be restricted to subsarcolemmal mitochondria. Thus, we evaluated mitoKATP channel characteristics and responsiveness in isolated interfibrillar mitochondria of wild-type mice. MitoKATP currents could be recorded in interfibrillar mitoplasts with single-channel properties similar to those of subsarcolemmal mitochondria (Figure (Figure6,6, A–E). However, single-channel activity of mitoKATP in interfibrillar mitoplasts was completely insensitive to PKC activation by both PMA and diazoxide (Figure (Figure6,6, A, B, and D). Importantly, baseline activity was inhibited by MgATP and glibenclamide, thus confirming mitoKATP channel identity (Figure (Figure6,6, A, B, and D). The absence of mitoKATP channel responsiveness to PKC and diazoxide stimulation in interfibrillar mitochondria further confirmed the fundamental role of Cx43 for mitoKATP channel activation and indicates functional compartmentation of mitochondria in cell signaling.

Figure 6
MitoKATP channel activity of interfibrillar mitochondria is insensitive to PKC and diazoxide (100 μM) stimulation.

Discussion

Cell protection involves activation of endogenous signaling, which can confer significant resistance to oxidant and other stresses associated with hypoxia/reoxygenation, thus promoting enhanced capacity for cell survival (13). Although mitoKATP channels have convincingly been demonstrated to serve as central effectors of diverse upstream cytoprotective signaling pathways, the actual mitochondrial proteins involved in this process are unknown (1, 5, 6, 8). Our results provide the first functional evidence to our knowledge of a mitoKATP channel complex in native mitochondria by linking Cx43 to mitoKATP channel opening. While purification of mitochondrial proteins and subsequent reconstitution in artificial lipid bilayers or proteosomes suggested that mitoKATP channels are incorporated in a multiprotein complex (26, 27), this process may be compromised by unspecific contamination, and protein association does not necessarily reflect functional interaction in native tissue. Moreover, specification of copurified proteins was largely based on immunoreactivity without detailed proteomic analysis, which bears the uncertainty of false-positive antibody cross-binding to unrelated proteins (8, 27). In the present study, we aimed to circumvent these limitations and show in isolated mitoplasts by a pharmacological, a peptide mimetic, and a genetic approach that Cx43 plays a key role in diazoxide- and PKC-induced mitoKATP channel stimulation, thus defining what we believe to be a novel functional role for Cx43.

Beyond cell-cell coupling, connexin hexamers, monomers, and C-terminal fragments are involved in cell signaling (28, 29). Our observation that carbenoxolone, which inhibits gap junctions and connexin hexamers (19), suppressed mitoKATP channel activation similarly to genetic Cx43 deficiency suggests that Cx43 in mitochondria forms hemichannels. While such hemichannels may conduct potassium and may be modulated by ATP (30), the presence of mitoKATP channels in interfibrillar mitochondria lacking Cx43 argues against the notion that Cx43 builds the conduction pore of mitoKATP channels. Existence of a channel pore that is distinct from Cx43 is further supported by the lower single-channel conductance of mitoKATP channels than reported for full and subconductance states of connexons and gap junctions (31). Rather, our results demonstrate that Cx43 is essential for cytoprotective signal transduction on mitoKATP channels, which is supported 7-fold, i.e., by reduced responsiveness of these channels in the presence of (a) pharmacological Cx43 inhibition, (b) Cx43 mimetic peptides, (c) genetic heterozygous Cx43 suppression, (d) almost complete Cx43 reduction in conditional genetic Cx43 knockdown mice, (e) additive effects of 43GAP27 with the genetic Cx43+/– suppression, (f) rescue of diazoxide sensitivity in Cx43+/– mice upon IP-induced Cx43 increase, and (g) absence of diazoxide/PKC response in interfibrillar mitochondria lacking Cx43.

In vivo and single-cell studies showed that both Cx43 and PKCε translocate to mitochondria during IP and are pivotal components of preconditioning (7, 10, 22). While the present experiments confirm an IP-mediated increase in mitochondrial Cx43, our results now in addition provide a functional link between these two proteins, with PKCε phosphorylating mitochondrial Cx43 in vitro and being upstream of Cx43 in cytoprotective signal cascades. Although our experiments may not discriminate whether IP and PKCε induce stimulation of mitoKATP channels through upregulation of mitochondrial Cx43 alone or additional Cx43 phosphorylation in vivo, our observation of Cx43-mediated mitoKATP channel regulation suffices to explain previous reports of abolished pharmacological and IP and reduced formation of ROS in Cx43+/– mice (911).

Emerging data indicate that localization of signaling molecules is a key component in cell function (32, 33). Mitochondria are known to be distributed in different subcellular compartments (25). Our data show that responsiveness to cytoprotective signal transduction via PKC and subsequently mitoKATP channels is restricted to subsarcolemmal mitochondria, which are localized adjacent to the upstream receptors. Conversely, interfibrillar mitochondria do not seem to be involved in these cytoprotective pathways, given the observed diazoxide and PKC insensitivity of their mitoKATP channels. Thus, our observations extend previous reports of distinct structure and biochemical properties of mitochondrial subgroups (25, 34), now indicating that these subpopulations are assigned to distinct cellular functions and suggesting that cardiac cytoprotection via mitoKATP channel activation is confined to a circumscribed subsarcolemmal compartment.

Understanding the mechanisms involved in cell protection enhances the expectation that one may pharmacologically intervene to block or modulate cell death. The fact that Cx43 regulates mitoKATP channel activity in native mitochondria makes Cx43 an attractive target for drug development against ischemic injury.

Methods

The present study was performed with approval by the Bioethical Committee of the Landesamt für Natur, Umwelt und Verbraucherschutz Nordrhein-Westfalen in Recklinghausen and conforms to the NIH Guide for the care and use of laboratory animals (publication no. 85-23. Revised 1996).

Mouse hearts.

Hearts were obtained from C57BL/6J mice, heterozygous Cx43+/– mice (35), and wild-type littermates, as indicated. More complete ablation of Cx43 was induced in adult Cx43Cre-ER(T)/fl mice by the intraperitoneal injection of 3 mg 4-OHT once per day on 5 consecutive days as previously described (10, 21). These animals were sacrificed at day 12 after the first injection. For control, Cx43fl/fl mice were used (10, 21).

Preparation of cardiomyocytes and subsarcolemmal/interfibrillar mitoplasts.

Single ventricular myocytes were isolated by enzymatic digestion, as previously described (36). Freshly isolated cardiomyocytes were used within 1–2 hours. Myocytes were labeled with Mitotracker Green (1 μM; Molecular Probes, Invitrogen) to facilitate identification of intact mitoplasts after further subcellular purification. Isolated intact subsarcolemmal mitoplasts were prepared from isolated myocytes by differential centrifugation, as previously reported (13, 3739). Briefly, myocytes were suspended for 30 minutes in a solution containing (in mM) 250 sucrose, 5 K-HEPES, and 1 CaCl2 to rupture the sarcolemma and spun at 1,500 g for 10 minutes. The supernatant containing the subsarcolemmal mitochondria was pelleted (8,500 g, 10 minutes, 4°C). The mitochondria were further purified by 2 additional centrifugation cycles (8,500 g, 10 minutes, 4°C) and the final pellet resuspended in K+ solution (in mM: 150 KCl, 5 K-HEPES, 1 CaCl2, pH 7.2).

Isolated intact interfibrillar mitoplasts were prepared from isolated murine hearts, as previously described (12). In brief, murine hearts were removed quickly after decapitation and were washed in buffer A (in mM: 100 KCl, 5 MgSO4, 50 3-[N-morpholino]-propanesulfonic acid (MOPS), 1 EGTA, 1 MgATP, pH 7.4). The ventricular tissue was minced in 10 ml/g buffer B (buffer A plus 0.04% BSA), homogenized in a Potter-Elvehjem grinder, and spun at 800 g for 10 minutes. The pellet containing the interfibrillar mitochondria was resuspended in buffer B, treated for 1 minute with nargase (8 U/g tissue [bacterial, type XXIV, Sigma-Aldrich]), homogenized with a Potter-Elvehjem grinder, and spun at 800 g for 10 minutes. The supernatant was further purified by an additional centrifugation cycle (8,000 g, 10 minutes, 4°C) and the final pellet resuspended in K+ solution (in mM: 150 KCl, 5 K-HEPES, 1 CaCl2, pH 7.2). Mitochondria were stored at 4°C for up to 48 hours for patch-clamp experiments. Mitoplasts were prepared from intact mitochondria prior to patching or protein preparation by osmotic shock or digitonin, as previously described (14, 40).

Single-channel recordings.

All experiments were performed in the mitoplast-attached configuration of the patch-clamp technique (180 test pulses of 150-ms duration at 1.67 Hz, if not indicated otherwise; sampling frequency, 10 kHz; corner frequency, 2 kHz) with symmetrical bath and pipette solution composed of (in mM): 150 KCl, 10 K-HEPES; pH was adjusted to 7.2 with KOH, as previously described (13, 38). Currents were recorded and digitized with an Axopatch 200B amplifier and Digidata 1200 interface (Axon Instruments) with the use of custom software (CDE-REVL-LEVL/X program, version 1.3) (41, 42).

Single-channel analysis.

Single-channel analysis was done using custom software only from 1-channel patches, as previously reported (13, 37, 43, 44). Linear leak and capacity currents were digitally subtracted using the average currents of nonactive sweeps. For detailed gating analysis, idealized currents were analyzed in 150-ms steps (unless otherwise indicated). Active sweeps were defined as those with at least 1 opening. The open probability of active sweeps (Po,active; defined as the occupancy of the open state during active sweeps), the availability (fraction of sweeps containing at least 1 channel opening), and Ipeak (the peak ensemble average current) were calculated at –60 mV (unless otherwise indicated). The total open probability (Po,total; defined as the occupancy of the open state during the total pulse duration) was analyzed for 9-second pulse durations at –60 mV of 180 sweeps with 150-ms duration or, if indicated, of continuous pulses. Single-channel amplitudes were determined by direct measurements of fully resolved openings for conductance calculations or as the maximum of Gaussian fits to amplitude histograms. Time constants of open time (τopen) and closed time histograms (τclosed) were obtained by simplex maximum likelihood estimation on all-level open and closed time distributions.

IP.

We used the in situ mouse heart model, as described previously (45, 46). Briefly, Cx43+/– mice were anesthetized with pentobarbital sodium (80 mg/kg i.p.). The temperature of the animals was kept stable between 36.6 and 37.4°C using heating pads, and the electrocardiogram was monitored continuously. After intubation (polyethlene-60 tubing), the animals were ventilated with a stroke rate of 130/min and a tidal volume of 1 ml with oxygen-supplemented room air. A midline thoracotomy and pericardiotomy were performed. The left anterior descending coronary artery was occluded 2–3 mm distal to the tip of the left auricle using a 7.0 silk suture and a small tube to form a snare. After 10 minutes occlusion, the hearts were reperfused for 10 minutes. At the end of the protocol, hearts were rapidly excised, the anterior and posterior walls were separated, and mitochondria or mitoplasts were isolated as described above (n = 3).

Western blot analysis.

Mitochondria were prepared as described above. Proteins were prepared from different isolation fractions (as indicated) with standard methods, as described previously (43). Protein concentration was assayed using a commercial protein assay (BCA method, Pierce). After standard Laemmli SDS-PAGE (12%) and Western blotting (Bio-Rad Tankblot system, nitrocellulose membrane), proteins were detected using the following primary antibodies: Cx43 (1:5,000, rabbit polyclonal, ab11370, Abcam), GAPDH (1:200, rabbit polyclonal IgG, sc-25778, Santa Cruz Biotechnology Inc.), Na+/K+-ATPase (1:1,000, rabbit polyclonal IgG, no. 3010, Cell Signaling Technology Inc.), sarcoplasmic reticulum Ca2+ pump gene 2 (SERCA2A; 1:100, goat polyclonal IgG, sc-8094, Santa Cruz Biotechnology Inc.), voltage-dependent anion channel (VDAC; 1:1,000, rabbit polyclonal IgG, no. 4866, Cell Signaling Technology Inc.), uncoupling protein 2 (UCP2; 1:100, goat polyclonal IgG, sc-6525, Santa Cruz Biotechnology Inc.), manganese superoxide dismutase (MN-SOD; 1:1,000, rabbit polyclonal IgG, Upstate), Cx43 phosphorylated at serine 368 (Cx43Ser368; 1:500, rabbit polyclonal IgG, Cell Signaling Technology Inc.), and horseradish peroxidase–coupled anti-rabbit secondary antibody (1:2,000, Sigma-Aldrich). Primary antibody incubations were performed overnight at 4°C. Immunoreactive bands were stained with ECL reagents (Amersham Pharmacia Biotech) according to the manufacturer’s instructions. Densitometrical analysis of protein induction was performed using a CCD camera (Raytest) with AIDA densitometry analysis software (Raytest). Each Western blot was performed in triplicate, unless otherwise indicated.

Immunoprecipitation of Cx43 with PKCε.

Proteins were prepared from isolated mitochondria. Samples (500 μg of mitochondrial protein) were incubated with anti-PKCε antibody (rabbit polyclonal anti-human, 20 μg, Santa Cruz Biotechnology Inc.), anti-Cx43 antibody (rabbit polyclonal anti-rat total Cx43, 25 μg, Zytomed), or anti-rabbit IgGs before binding to protein A. The beads were washed 3 times with 0.5 ml phosphate-buffered saline. Immunoprecipitated proteins were electrophoretically separated on 10% polyacrylamide gels and subsequently transferred to nitrocellulose membranes. Input lysates and total ventricular protein served as control. Immunoblotting against VDAC (1:1,000, rabbit polyclonal IgG, no. 4866, Cell Signaling Technology Inc.) was performed to exclude any unspecific coimmunoprecipitation. Primary antibody incubations were performed overnight at 4°C. Immunoreactive bands were detected using the SuperSignal West Femto Maximum Sensitivity Substrate (Pierce). Each immunoprecipitation was performed in triplicate.

PKC stimulation and Cx43 phosphorylation.

Mitochondria were isolated from the ventricles of male C57BL/6J mice and purified by Percoll gradient ultracentrifugation. Intact mitochondria were stimulated in incubation buffer (in mM: 125 KCl, 10 Tris-MOPS, 1.2 Pi-Tris, 1.2 MgCl2, 0.02 EGTA, 5 glutamate, 2.5 malate, pH 7.4) supplemented with 200 μM ATP for 30 minutes at 25°C with continuous shaking without or with the PKCε-activating peptide ΨεRACK (5 μM). After stimulation, mitochondrial proteins were isolated in 1× cell lysis buffer (containing in mM: 20 Tris pH 7.5, 150 NaCl, 1 EDTA, 1 EGTA, 2.5 sodium pyrophosphate, 1 β-glycerophosphate, 1 Na3VO4, 1% Triton X-100, 1 μg/ml leupeptin, supplemented with 1× Complete Protease Inhibitor Cocktail [Roche]). After sonication, the samples were centrifuged at 14,000 g for 10 minutes at 4°C. The protein concentration of the supernatant was determined using the Protein Dc Kit (Bio-Rad). Ten micrograms mitochondrial or right-ventricular proteins were subjected to Western blot analysis (see above). Signal intensities of Cx43Ser368 were normalized to the respective MN-SOD signals. MN-SOD immunoreactive signals were also normalized to Ponceau S staining to ensure that MN-SOD was suitable as a reference protein. Signals were quantified using Scion Image software (Scion Corp.).

Measurement of H2O2.

H2O2 generation was measured with Amplex UltraRed (Invitrogen) according to the manufacturer’s instructions. In brief, 10 μg intact mitochondria of C57BL/6J mice were incubated with 50 μM Amplex UltraRed and 0.1 U/ml horseradish peroxidase in incubation buffer (in mM: 125 KCl, 10 Tris-MOPS, 1.2 Pi-Tris, 1.2 MgCl2, 0.02 EGTA, 5 glutamate, 2.5 malate, pH 7.4) without or with antimycin A. In addition, H2O2 generation was measured from 50 μg mitoplasts in patch-clamp solution without or with antimycin A, diazoxide, or the vehicle DMSO, as indicated. Fluorescence was measured for 10 minutes continuously with a Varian Cary Eclipse spectrophotometer at excitation/emission wavelengths of 565/581 nm. Background fluorescence of the buffer without mitochondria was subtracted, and the slope was calculated.

Materials and statistical analysis.

In some experiments, MgATP, diazoxide, glibenclamide, 5-hydroxydecanoic acid, carbenoxolone (19), PMA, 4α-PMA, L-NAC (Sigma-Aldrich), the PKCε-specific activator peptide ψεRACK (HDAPIGYD, synthesized with stated purity >95% by EZBiolab) (7), and/or the Cx43 mimetic peptide 43GAP27 (SRPTEKTIFII, synthesized with stated purity >85% by Eurogentec) (20) were added to the bath solutions, as indicated. Pooled data are presented as mean ± SEM. Comparisons between groups were performed with 1-way ANOVA or 2-tailed Student’s t test (Cx43 phosphorylation). A P value less than 0.05 was considered significant.

Acknowledgments

We thank Nadine Henn and Iris Berg for technical assistance. This work was supported by grants from the Deutsche Forschungsgemeinschaft (Ho 2146/3-3, Schu 843/7-1, 7-2), Köln Fortune, and the Marga and Walter Boll-Stiftung (to U.C. Hoppe).

Footnotes

Conflict of interest: The authors have declared that no conflict of interest exists.

Citation for this article: J Clin Invest. 2010;120(5):1441–1453. doi:10.1172/JCI40927.

References

1. Murphy E. Primary and secondary signaling pathways in early preconditioning that converge on the mitochondria to produce cardioprotection. Circ Res. 2004;94(1):7–16. doi: 10.1161/01.RES.0000108082.76667.F4. [PubMed] [Cross Ref]
2. Pong K. Ischaemic preconditioning: therapeutic implications for stroke? Expert Opin Ther Targets. 2004;8(2):125–139. doi: 10.1517/14728222.8.2.125. [PubMed] [Cross Ref]
3. Heusch G, Boengler K, Schulz R. Cardioprotection: nitric oxide, protein kinases, and mitochondria. Circulation. 2008;118(19):1915–1919. doi: 10.1161/CIRCULATIONAHA.108.805242. [PubMed] [Cross Ref]
4. Goto M, Liu Y, Yang XM, Ardell JL, Cohen MV, Downey JM. Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. Circ Res. 1995;77(3):611–621. [PubMed]
5. O’Rourke B. Mitochondrial ion channels. Annu Rev Physiol. 2007;69:19–49. doi: 10.1146/annurev.physiol.69.031905.163804. [PMC free article] [PubMed] [Cross Ref]
6. Costa AD, Garlid KD. Intramitochondrial signaling: interactions among mitoKATP, PKCepsilon, ROS, and MPT. Am J Physiol Heart Circ Physiol. 2008;295(2):H874–H882. doi: 10.1152/ajpheart.01189.2007. [PubMed] [Cross Ref]
7. Dorn GW, II, et al. Sustained in vivo cardiac protection by a rationally designed peptide that causes epsilon protein kinase C translocation. Proc Natl Acad Sci U S A. 1999;96(22):12798–12803. doi: 10.1073/pnas.96.22.12798. [PubMed] [Cross Ref]
8. Foster DB, Rucker JJ, Marban E. Is Kir6.1 a subunit of mitoK(ATP)? Biochem Biophys Res Commun. 2008;366(3):649–656. doi: 10.1016/j.bbrc.2007.11.154. [PMC free article] [PubMed] [Cross Ref]
9. Heinzel FR, et al. Impairment of diazoxide-induced formation of reactive oxygen species and loss of cardioprotection in connexin 43 deficient mice. Circ Res. 2005;97(6):583–586. doi: 10.1161/01.RES.0000181171.65293.65. [PubMed] [Cross Ref]
10. Boengler K, et al. Connexin 43 in cardiomyocyte mitochondria and its increase by ischemic preconditioning. Cardiovasc Res. 2005;67(2):234–244. doi: 10.1016/j.cardiores.2005.04.014. [PubMed] [Cross Ref]
11. Li X, Heinzel FR, Boengler K, Schulz R, Heusch G. Role of connexin 43 in ischemic preconditioning does not involve intercellular communication through gap junctions. J Mol Cell Cardiol. 2004;36(1):161–163. doi: 10.1016/j.yjmcc.2003.10.019. [PubMed] [Cross Ref]
12. Boengler K, et al. Presence of connexin 43 in subsarcolemmal, but not in interfibrillar cardiomyocyte mitochondria. Basic Res Cardiol. 2009;104(2):141–147. doi: 10.1007/s00395-009-0007-5. [PubMed] [Cross Ref]
13. Er F, Michels G, Gassanov N, Rivero F, Hoppe UC. Testosterone induces cytoprotection by activating ATP-sensitive K+ channels in the cardiac mitochondrial inner membrane. Circulation. 2004;110(19):3100–3107. doi: 10.1161/01.CIR.0000146900.84943.E0. [PubMed] [Cross Ref]
14. Inoue I, Nagase H, Kishi K, Higuti T. ATP-sensitive K+ channel in the mitochondrial inner membrane. Nature. 1991;352(6332):244–247. doi: 10.1038/352244a0. [PubMed] [Cross Ref]
15. Zhou M, Diwu Z, Panchuk-Voloshina N, Haugland RP. A stable nonfluorescent derivative of resorufin for the fluorometric determination of trace hydrogen peroxide: applications in detecting the activity of phagocyte NADPH oxidase and other oxidases. Anal Biochem. 1997;253(2):162–168. doi: 10.1006/abio.1997.2391. [PubMed] [Cross Ref]
16. Forbes RA, Steenbergen C, Murphy E. Diazoxide-induced cardioprotection requires signaling through a redox-sensitive mechanism. Circ Res. 2001;88(8):802–809. doi: 10.1161/hh0801.089342. [PubMed] [Cross Ref]
17. Cortassa S, Aon MA, Winslow RL, O’Rourke B. A mitochondrial oscillator dependent on reactive oxygen species. Biophys J. 2004;87(3):2060–2073. doi: 10.1529/biophysj.104.041749. [PubMed] [Cross Ref]
18. Drose S, Hanley PJ, Brandt U. Ambivalent effects of diazoxide on mitochondrial ROS production at respiratory chain complexes I and III. Biochim Biophys Acta. 2009;1790(6):558–565. [PubMed]
19. Ye ZC, Wyeth MS, Baltan-Tekkok S, Ransom BR. Functional hemichannels in astrocytes: a novel mechanism of glutamate release. J Neurosci. 2003;23(9):3588–3596. [PubMed]
20. Chaytor AT, Evans WH, Griffith TM. Peptides homologous to extracellular loop motifs of connexin 43 reversibly abolish rhythmic contractile activity in rabbit arteries. J Physiol. 1997;503(Pt 1):99–110. doi: 10.1111/j.1469-7793.1997.099bi.x. [PubMed] [Cross Ref]
21. Eckardt D, et al. Functional role of connexin43 gap junction channels in adult mouse heart assessed by inducible gene deletion. J Mol Cell Cardiol. 2004;36(1):101–110. doi: 10.1016/j.yjmcc.2003.10.006. [PubMed] [Cross Ref]
22. Inagaki K, Begley R, Ikeno F, Mochly-Rosen D. Cardioprotection by epsilon-protein kinase C activation from ischemia: continuous delivery and antiarrhythmic effect of an epsilon-protein kinase C-activating peptide. Circulation. 2005;111(1):44–50. doi: 10.1161/01.CIR.0000151614.22282.F1. [PubMed] [Cross Ref]
23. Doble BW, Ping P, Kardami E. The epsilon subtype of protein kinase C is required for cardiomyocyte connexin-43 phosphorylation. Circ Res. 2000;86(3):293–301. [PubMed]
24. Baines CP, et al. Mitochondrial PKCepsilon and MAPK form signaling modules in the murine heart: enhanced mitochondrial PKCepsilon-MAPK interactions and differential MAPK activation in PKCepsilon-induced cardioprotection. Circ Res. 2002;90(4):390–397. doi: 10.1161/01.RES.0000012702.90501.8D. [PubMed] [Cross Ref]
25. Palmer JW, Tandler B, Hoppel CL. Biochemical properties of subsarcolemmal and interfibrillar mitochondria isolated from rat cardiac muscle. J Biol Chem. 1977;252(23):8731–8739. [PubMed]
26. Jaburek M, Costa AD, Burton JR, Costa CL, Garlid KD. Mitochondrial PKC epsilon and mitochondrial ATP-sensitive K+ channel copurify and coreconstitute to form a functioning signaling module in proteoliposomes. Circ Res. 2006;99(8):878–883. doi: 10.1161/01.RES.0000245106.80628.d3. [PubMed] [Cross Ref]
27. Ardehali H. Signaling mechanisms in ischemic preconditioning: interaction of PKCepsilon and MitoK(ATP) in the inner membrane of mitochondria. Circ Res. 2006;99(8):798–800. doi: 10.1161/01.RES.0000247029.31997.a4. [PubMed] [Cross Ref]
28. Goodenough DA, Paul DL. Beyond the gap: functions of unpaired connexon channels. Nat Rev Mol Cell Biol. 2003;4(4):285–294. doi: 10.1038/nrm1072. [PubMed] [Cross Ref]
29. Jiang JX, Gu S. Gap junction- and hemichannel-independent actions of connexins. Biochim Biophys Acta. 2005;1711(2):208–214. [PMC free article] [PubMed]
30. Sugiura H, Toyama J, Tsuboi N, Kamiya K, Kodama I. ATP directly affects junctional conductance between paired ventricular myocytes isolated from guinea pig heart. Circ Res. 1990;66(4):1095–1102. [PubMed]
31. Saez JC, Retamal MA, Basilio D, Bukauskas FF, Bennett MV. Connexin-based gap junction hemichannels: gating mechanisms. Biochim Biophys Acta. 2005;1711(2):215–224. [PMC free article] [PubMed]
32. Weiss JN, Korge P. The cytoplasm: no longer a well-mixed bag. Circ Res. 2001;89(2):108–110. [PubMed]
33. Mochly-Rosen D. Localization of protein kinases by anchoring proteins: a theme in signal transduction. Science. 1995;268(5208):247–251. doi: 10.1126/science.7716516. [PubMed] [Cross Ref]
34. Riva A, Tandler B, Loffredo F, Vazquez E, Hoppel C. Structural differences in two biochemically defined populations of cardiac mitochondria. Am J Physiol Heart Circ Physiol. 2005;289(2):H868–H872. doi: 10.1152/ajpheart.00866.2004. [PubMed] [Cross Ref]
35. Reaume AG, de Sousa PA, Kulkarni S, Langille BL, Zhu D, Davies TC, Juneja SC, Kidder GM, Rossant J. Cardiac malformation in neonatal mice lacking connexin43. Science. 1995;267(5205):1831–1834. doi: 10.1126/science.7892609. [PubMed] [Cross Ref]
36. Rottlaender D, Matthes J, Vatner SF, Seifert R, Herzig S. Functional adenylyl cyclase inhibition in murine cardiomyocytes by 2’(3’)-O-(N-methylanthraniloyl)-guanosine 5ι-[gamma-thio]triphosphate. J Pharmacol Exp Ther. 2007;321(2):608–615. doi: 10.1124/jpet.106.118422. [PubMed] [Cross Ref]
37. Michels G, et al. Two distinct human voltage-gated Ca2+-channels regulate cardiac mitochondrial Ca2+-uptake. Circulation. 2009;119(18):2435–2443. doi: 10.1161/CIRCULATIONAHA.108.835389. [PubMed] [Cross Ref]
38. Xu W, et al. Cytoprotective role of Ca2+- activated K+ channels in the cardiac inner mitochondrial membrane. Science. 2002;298(5595):1029–1033. doi: 10.1126/science.1074360. [PubMed] [Cross Ref]
39. Kirichok Y, Krapivinsky G, Clapham DE. The mitochondrial calcium uniporter is a highly selective ion channel. Nature. 2004;427(6972):360–364. doi: 10.1038/nature02246. [PubMed] [Cross Ref]
40. Siemen D, Loupatatzis C, Borecky J, Gulbins E, Lang F. Ca2+-activated K channel of the BK-type in the inner mitochondrial membrane of a human glioma cell line. Biochem Biophys Res Commun. 1999;257(2):549–554. doi: 10.1006/bbrc.1999.0496. [PubMed] [Cross Ref]
41. Gassanov N, Brandt MC, Michels G, Lindner M, Er F, Hoppe UC. Angiotensin II-induced changes of calcium sparks and ionic currents in human atrial myocytes: potential role for early remodeling in atrial fibrillation. Cell Calcium. 2006;39(2):175–186. doi: 10.1016/j.ceca.2005.10.008. [PubMed] [Cross Ref]
42. Lange PS, Er F, Gassanov N, Hoppe UC. Andersen mutations of KCNJ2 suppress the native inward rectifier current I(K1) in a dominant-negative fashion. Cardiovasc Res. 2003;59(2):321–327. doi: 10.1016/S0008-6363(03)00434-6. [PubMed] [Cross Ref]
43. Michels G, et al. K+ channel regulator KCR1 suppresses heart rhythm by modulating the pacemaker current If. PLoS ONE. 2008;3(1):e1511. doi: 10.1371/journal.pone.0001511. [PMC free article] [PubMed] [Cross Ref]
44. Michels G, Er F, Khan IF, Südkamp M, Herzig S, Hoppe UC. Single-channel properties support a potential contribution of HCN channels and If to cardiac arrhythmias. Circulation. 2005;111(4):399–404. doi: 10.1161/01.CIR.0000153799.65783.3A. [PubMed] [Cross Ref]
45. Guo Y, Wu WJ, Qiu Y, Tang XL, Yang Z, Bolli R. Demonstration of an early and a late phase of ischemic preconditioning in mice. Am J Physiol. 1998;275(4 Pt 2):H1375–H1387. [PMC free article] [PubMed]
46. Schwanke U, Konietzka I, Duschin A, Li X, Schulz R, Heusch G. No ischemic preconditioning in heterozygous connexin43-deficient mice. Am J Physiol Heart Circ Physiol. 2002;283(4):H1740–H1742. [PubMed]

Articles from The Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation